A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX after chemotherapy in patients with recurrent epithelial ovarian carcinoma
2017 ◽
Vol 28
◽
pp. v626
◽
J. Ledermann
◽
J. Sehouli
◽
B. Zurawski
◽
F. Raspagliesi
◽
U. De Giorgi
◽
...
2014 ◽
Vol 32
(15_suppl)
◽
pp. TPS5622-TPS5622
Jonathan A. Ledermann
◽
Ingo von Broen
◽
Frank Zimmermann
◽
Johannes Nippgen
◽
Steffen Goletz
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A617.2-A618
W. Kennedy
◽
P. Horn
◽
Z. Su
◽
K. Basu
◽
A. Herman
◽
...
Yoshiya Tanaka
◽
Tsutomu Takeuchi
◽
Hisashi Yamanaka
◽
Toshihiro Nanki
◽
Hisanori Umehara
◽
...
Eunice S Wang
◽
Roger M Lyons
◽
Richard A Larson
◽
Sunil Gandhi
◽
Delong Liu
◽
...
Yoshiya Tanaka
◽
Tsutomu Takeuchi
◽
Hisashi Yamanaka
◽
Toshihiro Nanki
◽
Hisanori Umehara
◽
...
2004 ◽
Vol 43
(5)
◽
pp. A254
Ralph M Vicari
◽
Bernard Chaitman
◽
Deborah Keefe
◽
William B Smith
◽
Steven G Chrysant
◽
...
2022 ◽
Vol 7
(1)
◽
pp. 100311
J.A. Ledermann
◽
B. Zurawski
◽
F. Raspagliesi
◽
U. De Giorgi
◽
J. Arranz Arija
◽
...
2014 ◽
Vol 37
(12)
◽
pp. 3253-3261
◽
Aaron Vinik
◽
Julio Rosenstock
◽
Uma Sharma
◽
Karen Feins
◽
Ching Hsu
◽
...
2014 ◽
Vol 10
◽
pp. P275-P275
◽
Jeffrey Cummings
◽
William Cho
◽
Michael Ward
◽
Michel Friesenhahn
◽
Flavia Brunstein
◽
...
Close
Export Citation Format
Close
Share Document
Close